The Beacon Checkpoint Team, along with the organisers of the 2023 Adenosine-Targeted Cancer Immunotherapies Summit, have crafted this infographic to provide you with a comprehensive picture of the adenosine Landscape.

Download the infographic to get truest representation of the competitive landscape for adenosine-targeted Immunotherapeutics. At a time where the field is in a holding pattern awaiting the result of this cornerstone phase 3 trial, now is the time to get the lay of the land and prepare for the road ahead.

It is curated with information covering 77 assets, across 11 years of development, 11 different cancers and more!